196 related articles for article (PubMed ID: 35008634)
1. TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in Breast Cancer.
Li JN; Chen PS; Chiu CF; Lyu YJ; Lo C; Tsai LW; Wang MY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008634
[TBL] [Abstract][Full Text] [Related]
2. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells.
Zhou J; Zhang S; Xue J; Avery J; Wu J; Lind SE; Ding WQ
J Biol Chem; 2012 Oct; 287(42):35161-35169. PubMed ID: 22932900
[TBL] [Abstract][Full Text] [Related]
4. Foxp3 enhances HIF-1α target gene expression in human bladder cancer through decreasing its ubiquitin-proteasomal degradation.
Jou YC; Tsai YS; Lin CT; Tung CL; Shen CH; Tsai HT; Yang WH; Chang HI; Chen SY; Tzai TS
Oncotarget; 2016 Oct; 7(40):65403-65417. PubMed ID: 27557492
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α Upregulation due to Depletion of the Free Ubiquitin Pool.
Kim J; So D; Shin HW; Chun YS; Park JW
J Korean Med Sci; 2015 Oct; 30(10):1388-95. PubMed ID: 26425034
[TBL] [Abstract][Full Text] [Related]
6. Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.
Liu J; Zhang C; Zhao Y; Yue X; Wu H; Huang S; Chen J; Tomsky K; Xie H; Khella CA; Gatza ML; Xia D; Gao J; White E; Haffty BG; Hu W; Feng Z
Nat Commun; 2017 Nov; 8(1):1823. PubMed ID: 29180628
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity.
Park MH; Bae SS; Choi KY; Min do S
Exp Mol Med; 2015 Nov; 47(11):e196. PubMed ID: 26611735
[TBL] [Abstract][Full Text] [Related]
8. AK-1, a SIRT2 inhibitor, destabilizes HIF-1α and diminishes its transcriptional activity during hypoxia.
Lee SD; Kim W; Jeong JW; Park JW; Kim JE
Cancer Lett; 2016 Apr; 373(1):138-145. PubMed ID: 26808575
[TBL] [Abstract][Full Text] [Related]
9. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation.
Amelio I; Inoue S; Markert EK; Levine AJ; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):226-31. PubMed ID: 25535359
[TBL] [Abstract][Full Text] [Related]
10. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha.
Luo W; Zhong J; Chang R; Hu H; Pandey A; Semenza GL
J Biol Chem; 2010 Feb; 285(6):3651-3663. PubMed ID: 19940151
[TBL] [Abstract][Full Text] [Related]
11. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.
Kong X; Lin Z; Liang D; Fath D; Sang N; Caro J
Mol Cell Biol; 2006 Mar; 26(6):2019-28. PubMed ID: 16507982
[TBL] [Abstract][Full Text] [Related]
13. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.
Yi T; Papadopoulos E; Hagner PR; Wagner G
J Biol Chem; 2013 Jun; 288(26):18732-42. PubMed ID: 23667251
[TBL] [Abstract][Full Text] [Related]
15. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
16. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy.
Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G
PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
18. Spermidine/spermine N(1)-acetyltransferase-1 binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1alpha.
Baek JH; Liu YV; McDonald KR; Wesley JB; Zhang H; Semenza GL
J Biol Chem; 2007 Nov; 282(46):33358-33366. PubMed ID: 17875644
[TBL] [Abstract][Full Text] [Related]
19. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha.
Baek JH; Mahon PC; Oh J; Kelly B; Krishnamachary B; Pearson M; Chan DA; Giaccia AJ; Semenza GL
Mol Cell; 2005 Feb; 17(4):503-12. PubMed ID: 15721254
[TBL] [Abstract][Full Text] [Related]
20. Identification of an alternative mechanism of degradation of the hypoxia-inducible factor-1alpha.
André H; Pereira TS
J Biol Chem; 2008 Oct; 283(43):29375-84. PubMed ID: 18694926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
